|
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Inigo Espinosa, MD a, Cheng-Han Lee, MD, PhDa, Mi Kyung Kim, MD, PhD a, Bich-Tien Rouse, MSa, Subbaya Subramanian, PhD a, Kelli Montgomery a, Sushama Varma, MS a Christopher L. Corless, MD, PhD b, Michael C. Heinrich, MD b, Kevin S. Smith, PhDa, Zhong Wang, PhDa, Brian Rubin MD, PhDc, Torsten O Nielsen MD, PhDd, Robert S Seitz MDe, Douglas T Ross, MD, PhDe , Robert B West, MD, PhDa, Michael L. Cleary, MDa, and Matt van de Rijn, MD, PhDa |
